PART I: A COMPARISON
The measurement of the lead or coproporphyrin content of urine samples is the usual screening test used throughout industry. When a number of people are employed in the same environment the results can be used in two ways. Hamlin and Weber (I947) and Zielhuis (i96ia) have shown that the average urinary lead or coproporphyrin concentration of a group of men indicates the atmospheric lead concentration to which the group is exposed. Thus by measuring the group average lead and coproporphyrin excretions at regular intervals the lead hazard can be monitored with a reasonable degree of accuracy. The absorption of lead by the individual is assessed by comparing the concentration of each specimen against the maximum urinary concentration (M.U.C.). The M.U.C. is defined as the highest concentration which can be found in the urine without damage to health. Unfortunately there is a considerable divergence of opinion as to the level of the M.U.C., which is in part due to differing definitions of 'health'. Moreover, Buch- wald (I964) pointed out that there is some disagreement concerning the collection of the specimen and the manner in which the results of urine analysis should be expressed. It is well known that urine specimens show biological variation, the greatest variability being associated with the results from single voidings.
It appears that although the atmospheric pollution can be satisfactorily monitored by urine analysis the protection afforded to the individual is uncertain.
It is the object of this paper to compare the efficacy of the various factors which are considered when the results of urine analysis are used to assess the degree of lead absorption. For convenience, this work is divided into a consideration of the results of single voidings and of cumulative samples. 263
Variability of Single Voidings of Urine
Most firms rely on the analysis of spot specimens of urine for their screening tests. These show extreme variability and several methods have been suggested to reduce this scatter. It has been proposed that corrections should be made for the time over which the urine is excreted (Barnes, I939) , the volume (Kehoe, Cholak, Hubbard, Bambach, McNary and Story, I940) , a combination of time and volume (Pinto, Elkins, and Ege, 194I) , the specific gravity (Levine and Fahy, I945) , and the creatinine concentration (Smith and Kench, I957) . Molyneux (I964) has proposed that the specimen should be collected at a specified time of day.
This investigation was carried out to determine three things: first, the extent of the variation encountered in spot urinary lead and coproporphyrin concentrations and excretion rates; secondly, the value of adjustment for specific gravity and creatinine in reducing the scatter; and finally, the contribution of the diurnal rhythm to the variability.
Experimental Data It is difficult to collect serial urine specimens from active leadworkers. For this reason consecutive specimens were obtained from five hospital in-patients. The men had all had an industrial exposure to lead and showed clinical evidence of excessive absorption. A set of specimens was collected from each man before he was treated with chelating agents. A further set was provided by one of the men while he was convalescing one week after therapy. When the volume was sufficient each sample was analysed for lead (Dick, Ellis, and Steel, I96I) , coproporphyrin (Rimington and Sveinsson, I950) , and creatinine content (Varley, I962) . The specific gravity was measured and the time of each voiding was recorded.
The experimental data are given in the Appendix to this paper (p. 276) . Each figure in the Tables represents the mean of duplicate or, in the case of lead, triplicate analyses. The 'mean concentration' of each metabolite was determined for each series. This 'mean concentration' was calculated as the total weight of the constituent excreted divided by the total volume of urine collected, i.e., the result ofa single cumulative sample (this value will be placed in inverted commas throughout the remainder of the paper). Thus Young, and Weissman (1959) thought that the specific gravity, as a measure of the renal concentrating ability, is only valid when the specific gravity exceeds I1020. Price, Miller, and Hayman (I940) showed that the estimation of total urinary solids from the specific gravity is only valid for urines of the same relative composition and that spot specimens are inaccurate due to variations in the solids content. These and other criticisms have led to several investigators suggesting the creatinine concentration as a reference point. However, Bleiler and Schedl (I962) , who measured the variability of the creatinine content in 24-hour collections of urine, concluded that the use of creatinine excretion as a reference in interpreting the excretion of other metabolites may be invalid when based on single voidings.
So that the results for the different men and the value of adjustment for specific gravity and creatinine can be compared, each value of the lead and coproporphyrin concentrations was expressed as a proportion of the 'mean concentration' of the series. The lead and coproporphyrin concentrations were adjusted to a constant specific gravity of i-ox6 and expressed as a proportion of the 'mean concentration' according to the equation: Us
where Usg is the adjusted proportionate value, U0
is the observed concentration (,ug./litre), GE is (standard specific gravity -i) x iooo = I6, Go is (observed specific gravity -i) x iooo, and M is the 'mean concentration' (,ug. /litre). In a similar fashion the lead and coproporphyrin proportions were adjusted to the 'mean creatinine concentration' of the series by the formula: Table I .
The opinion that the increase in variability of the specific gravity corrected figures is due to the inclusion of urines of low specific gravity is not substantiated in this investigation. Patients C and P2 excreted urines ranging from S.G. IOO4 to iioi6 and S.G. I-OO4 to 102o respectively. Specific gravity adjustment of C's results reduced the lead and coproporphyrin coefficients ofvariation by about a third, whereas in P2's case adjustment increased both coefficients of variation by half as much again. Furthermore, when specific gravity correction was applied to K's results the coefficient of variation of the lead values was increased but the coefficient of variation of the coproporphyrin figures was reduced. Patient P provided a set of specimens before and after treatment with chelating agents (series P and P2). Before therapy both the lead and coproporphyrin coefficients of variation were reduced by specific gravity correction but after medication adjustment increased both coefficients of variation. It is apparent that there is no simple criterion which indicates when specific gravity adjustment would reduce the variability of the concentrations.
The figures expressed as rates of excretion and as at a definite trend. When the scatter of the spot values about the 'mean concentration' is considered, it is found that there are insufficient data from any one man to arrive at a definite conclusion as to the shape of the distribution. By using the proportionate values, all the figures can be pooled to provide a sufficient number. In Fig. 7 it can be seen that the square roots of the proportions lie in an approximately normal distribution, whereas the proportions and the logarithms of the proportions fall in slightly skewed curves.
If the averages of a number of specimens are taken, these averages will be arranged about the arithmetical mean concentrations in a less skewed distribution, and the variability will be reduced by the factor I/Vin where n is the number of results providing the average. Thus, in order to obtain a reliable measure of the excretion level, the spot specimens must be considered collectively. This can be done either by statistical methods or by collecting cumulative samples of urine.
Cumulative Samples
A major difficulty in examiining the reliability of cumulative urine samples as a method of assessing the lead absorption is to obtain an objective measure of the lead absorption of the individual. However, an indication can be gained by treating the man with chelating agents. Teisinger and Srbova (I959) and Rieders (I960), among others, have suggested that the lead excretion after the initial intravenous infusion of disodium calcium ethylenediaminetetraacetate (first Pb EDTA) provides a measure of the lead absorption. Cramer and Selander (i965) considered that 'a more or less objective measure' of the lead absorption was provided by the total weight of lead excreted in the urine during treatment with 9 g. oral penicillamine by divided doses. When a leadworker is given chelating agents not only is there a dramatic rise in the urinary lead excretion but there is also a marked fall in the coproporphyrinuria. It appears that the decrease in the coproporphyrin excretion is related to the amount of lead excreted as the complex. A further indication of the lead absorption is thus provided by the 'excess' lead, which is the weight of lead excreted as the complex before the coproporphyrin excretion falls to a normal level (less than ioo jig. per day).
In this part of the work comparisons are made in the relationships between the pretreatment urine analyses and the lead absorption as measured by the first Pb EDTA and the 'excess' lead.
Experimental Data The subjects in this part of the investigation were hospital in-patients who had all been exposed to an industrial lead hazard. The results of correlation analyses (Table III) reveal that the excretion levels of lead and coproporphyrin indicate both the first Pb EDTA and the 'excess' lead. It is useful to consider which mode of expression of which metabolite provides the more reliable guide to the lead absorption. In Table III it can be seen that the results expressed as the daily excretions (,tg./24 hours) have higher correlations than those expressed as concentrations (,ug. /litre). Furthermore, the coproporphyrin correlation coefficients are higher than the corresponding lead values. To determine whether these differences are statistically significant, each correlation can be compared with all the others by an application of Duncan's multiple comparison method (James, I964) . It is found that the 36 comparisons evolved from the nine correlation coefficients show no significant differences. This observation demonstrates that the degree of lead absorption is equally reflected by the lead and coproporphyrin urinary excretion levels, regardless of how the results are reported. Statistically significant differences might, of course, emerge if more patients were included in further studies.
The practical application of the above conclusions will now be considered. The hospital patients who provided the specimens were living under carefully It is suggested that leadworkers can be protected against absorbing an excessive quantity of lead by observing changes in the urinary excretions of lead or coproporphyrin. The collection of urine and the method of reporting the results should be standardized within each factory. A simple statistical method is described by which the mean excretion level and significant changes in that level can be deduced.
In 1949 Lane pointed out that, when the lead absorption of a group of men exceeds a certain level, cases of plumbism are likely to occur, but not necessarily in those individuals with the higher lead concentrations in the urine. Furthermore, Zielhuis (i96ib) found that if the maximum urinary concentration for coproporphyrin was taken as 4 on the 'Donath scale'-equivalent to 400 ,ug./litre-although 83% of workers with a haemoglobin concentration of less than I2-8 g./Ioo ml. would be detected, I I% of those with a haemoglobin level of more than I4-7 g./Io0 ml. would also be compelled to discontinue their exposure. In Table II it can be seen that patient W passed urine of which both the lead and coproporphyrin content fell within the non-exposed range, i.e., less than 6o ,ug. lead and 120 jig. coproporphyrin per litre of urine. Yet this same man exhibited several clinical signs and symptoms of excessive lead absorption. It seems that there is no lower limit for excreted metabolites below which clinical evidence of excessive lead absorption does not appear. This implies that to provide adequate protection for all men each man must be considered separately.
It can be assumed that the urinary excretion levels of lead and coproporphyrin, for each man, are related both to his exposure and to his absorption, and, further, that his absorption depends on his exposure. Provided that a man is in equilibrium with his exposure then his excretion levels of both metabolites will be constant, and if he is healthy then his condition will not deteriorate while his absorption remains constant. Different men tolerate lead differently, and the urinary excretion of metabolites depends on numerous factors. It appears that rather than compare each result with the M.U.C. it would be a more practicable method of screening the personnel to detect changes in the excretion levels. This in turn raises the problem of whether a change, which has occurred, is due to biological variation or is in fact due to a change in the hazard.
If specimens of about 4 litres of urine are taken the biological variation will be reduced to a minimum. However, the collection of these large specimens presents some difficulties when workpeople are allowed to contribute urine without supervision. Unless the personnel are of high integrity false or contaminated specimens are likely to be sent for analysis. This same objection applies equally to 24-hour urine collections. It is often more convenient to obtain a spot specimen when the man visits the medical centre.
Unfortunately, spot specimens show greater variability than any cumulative sample. Furthermore, the concentrations of metabolites tend to rise as the working day progresses. In addition, each individual has his own diurnal rhythm. So as to reduce these effects it is necessary that all specimens should be collected at a time specified in relation to the working period. Probably the best time would be at the beginning of the shift when the average excretion and hence the variability is at a minimum.
If a large number of spot specimens (about 30 to 40) are analysed during a period when the individual is in equilibrium with his environment, the biological variation can be measured. However, it was shown in Part I that the square roots of the concentrations fall in a normal distribution about the average excretion level. It is therefore possible to devise a quality control method, which, by providing estimates of the average and of the variability, will indicate statistically significant changes in the mean excretion level. The method described below was originally designed for the interpretation of spot specimens but can be applied to most screening tests. Pearson (1935) , Davies (I949), and Moroney (I953).
The Control Method From the above theory a simple method has been devised. The method indicates the excretion level and the 9O% confidence limits from groups of four consecutive samples. The average of four samples was chosen because the 9O% limits can be estimated by multiplying the average range by 0o3997 (which for practical purposes is 4/10). In this scheme, significant changes in the level are indicated when any independent group average exceeds the limits deduced from previous groups. Since the method was designed for routine investigations the observed results are used instead of the square roots of the concentrations. The method is still applicable, however. As the limits are arranged symmetrically about the mean level more than one average in 20 would be expected to lie above the upper limit and less than one in 20 below the lower limit, although only one in I0 would fall beyond either limit. The loss in accuracy is more than offset by the time saved and by reducing the arithmetical errors which could arise. For work of higher precision the square roots of the concentrations could be used. -----------------d^,. 
Months
The record form consists of II columns divided into groups of four down the page. The first column is for the date which fixes the points on the ordinate of the chart. The second column shows the observed results. The moving average of four consecutive results is placed in column three. The remainder of the columns can only be used with independent groups of four results. Column 4 shows the sum of the independent group averages which, when divided by the number of groups, gives the grand average of all the observed results, and this is placed in column 5. The next four columns are used to calculate the 90% confidence limits. Column 6 shows the range (the difference between the highest and the lowest in the group). Column 7 shows the sum of the ranges which when divided by the number of groups gives the average range. This is placed in column 8. In column 9, the average range is multiplied by 4/10 to convert the average range to 90% confidence limit. Column IO gives the grand mean (column 5) plus the limit value, and column ii gives the grand mean minus the limit value, thus giving the upper and lower confidence limits.
Interpretation of the Record Form and Chart Figures IO and i i were derived from the data in Tables V and VI which As the results were obtained and the chart built up it was seen that his excretion level remained constant. The precision of both the grand mean and the limits increased as more data were collected.
It will be noted that although this man appears to be excreting an exorbitant quantity of coproporphyrins, he was healthy throughout this period (haemoglobin never below I4-7 g. /Ioo ml.). However, he was working under adverse conditions and usually passed small volumes of concentrated urine. Figure ii shows the results of a man with an excretion level stable for eight months followed by a rise over the remaining period. The spot results (shown as 'Xs') are difficult to interpret but the moving average (the broken line) demonstrates a continual upward trend. In Table VI ('Xs') point to a return to the low level, the third group average is significantly higher than the previous averages. This result could have been a chance observation but it is essential to consider each rise above the limit as being due to some ascribable reason before attributing it to chance. In fact the man had moved to a different department and was found to be healthy so he was allowed to remain at the new job. Since the man has a higher excretion level the results of the first two groups cannot be used with the latter values, so a new series begins. This notion of discarding all the results of a previous stable period must be adopted since the scatter and hence the limits depend on the excretion level (see Part I). If this is not done, when the level rises the limits will be too close together; conversely, when the level falls the limits will be too wide apart. This will make it more difficult to detect changes in the excretion levels.
Provided a standard procedure is adopted for the collection of the urine and the manner in which the results are expressed, this scheme will indicate significant changes in the excretion levels. Considerable care is needed in the interpretation of the data. It is possible to detect a significant fall in the metabolite concentration yet the man may be exposed to a greater hazard. One circumstance in which this paradoxical situation could arise is when a man, who has been in equilibrium with an extremely hot thermal environment at low risk and is then transferred to a normal environment at a higher risk, has specimens collected towards the end of the shift. It is apparent that some more reliable guide to the lead absorption must be measured, as well as having the man clinically examined, whenever a significant change in the metabolite level is detected and whenever the man changes his job. 
